(CL-301) Advanced Pharmacometrics PK/PD Modeling Course using Phoenix NLME
BUY NOW - $2995
This course is designed to explore advanced techniques in pharmacokinetic and pharmacodynamics modelling and simulation that are directly applicable to current challenges in drug development. In depth theory is coupled with examples from current literature to provide a complete training experience. Topics include complicated population pharmacokinetic models, PK/PD modelling of oncology studies, modelling transit compartments, target mediated drug disposition, and extrapolation from adults to children.
The fee is in US dollars and includes training materials, tea, coffee and lunch.
All travel, accommodation and evening meal expenses are the responsibility of the attendee.
All attendees are required to provide their own laptop for use during the course. Please bring a computer mouse.
A temporary version of the software will be provided in a downloadable format to those attendees who need it approximately two weeks prior to the course.
Software Used: Phoenix NLME
Prerequisites: Previous attendance at the introductory level NLME course is necessary to have a good understanding of Phoenix NLME and the user model language.
Serge Guzy acquired his chemical engineering degree in 1982 from the University of Brussels and received his master degree in chemistry and biophysics in 1985 from the Weizmann Institute. Serge obtained his Doctorate in biomedical engineering in 1990 from the Technion and one year later got his post-doctorate degree from UC Berkeley in chemical engineering and held a faculty position at UCSF School of Pharmacy between 1991-1996. Since that time Serge headed the Pharmacometrics at XOMA, Biotech, and founded POP-PHARM with the end of providing consulting and software development in support of drug development. With more than 25 years of experience with modeling and simulation, Serge Guzy established new methods for statistical population approaches in drug development, based on Monte Carlo simulation algorithms. The resulting MC-PEM methodology and Population software development made him internationally recognized. These new tools have already been well utilized in drug development. POP-PHARM signed a strategic alliance with Certara with the main goal in developing the Phoenix NLME engine and providing state of the art advanced population PK/PD training classes.
Expand all / Collapse all
|PAGE Workshop - Advanced NLME 5-6 June 2017||6/5/2017 9:00:00 am||6/6/2017 5:00:00 pm||Novotel Budapest at PAGE Conference|
|Crete, Greece (October 5-6, 2017)||10/5/2017 9:00:00 am||10/6/2017 5:00:00 pm||Crete, Greece|
- Standard Agenda
- End of Classroom Course Survey